Starting on October 3, Moderna's next-generation bivalent vaccine available to eligible persons in second phase
The Central Epidemic Command Center (CECC) announced that, starting October 3, Moderna's next-generation bivalent COVID-19 vaccine will be available to eligible individuals as a booster shot in the second phase of its rollout program. A minimum interval of 12 weeks (84days) is recommended between this vaccine and the last dose of a primary series vaccination/additional dose or the previous booster dose.
Please click here to see further details.
- Created:2022-10-03
- Last Updated:2022-10-19
- Count Views: